
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association of Medication Treatment for Opioid Use Disorder With Suicide Mortality
Bradley V. Watts, Daniel J. Gottlieb, Natalie Riblet, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 4, pp. 298-304
Closed Access | Times Cited: 32
Bradley V. Watts, Daniel J. Gottlieb, Natalie Riblet, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 4, pp. 298-304
Closed Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
State alignment with federal regulations in 2022 to relax buprenorphine 30-patient waiver requirements
Anita Silwal, Jeffery Talbert, Robert Bohler, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 7, pp. 100164-100164
Open Access | Times Cited: 15
Anita Silwal, Jeffery Talbert, Robert Bohler, et al.
Drug and Alcohol Dependence Reports (2023) Vol. 7, pp. 100164-100164
Open Access | Times Cited: 15
Stimulant medication and suicide mortality in attention-deficit hyperactivity disorder
Korie Rice, Talya Peltzman, Daniel J. Gottlieb, et al.
BJPsych Open (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Korie Rice, Talya Peltzman, Daniel J. Gottlieb, et al.
BJPsych Open (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
The Effects of Psychostimulant Prescription on Opioid Use Disorder Among People with Co-Occurring Adhd
Mohammad Yaseliani, Youngsuhk Jo, L. Lindo, et al.
(2025)
Closed Access
Mohammad Yaseliani, Youngsuhk Jo, L. Lindo, et al.
(2025)
Closed Access
Pain Management for Patients With Opioid Use Disorders
Abbie Lyden, Rachel Neu
Orthopaedic Nursing (2025) Vol. 44, Iss. 1, pp. 42-51
Closed Access
Abbie Lyden, Rachel Neu
Orthopaedic Nursing (2025) Vol. 44, Iss. 1, pp. 42-51
Closed Access
Racial Inequality in Receipt of Medications for Opioid Use Disorder in Nationwide Outpatient Settings—A Cross-sectional Study
Jingna Feng, Yuting Huang, Yichen Wang, et al.
Journal of General Internal Medicine (2025)
Closed Access
Jingna Feng, Yuting Huang, Yichen Wang, et al.
Journal of General Internal Medicine (2025)
Closed Access
Harm Reduction as an Essential Psychiatric Mental Health Nursing Skill
Brayden Kameg
Journal of the American Psychiatric Nurses Association (2025)
Closed Access
Brayden Kameg
Journal of the American Psychiatric Nurses Association (2025)
Closed Access
Epidemiology of Opioid Use, Misuse, and Overdoses
Khaled Draghmeh, Mark S. Gold, Brian Fuehrlein
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Khaled Draghmeh, Mark S. Gold, Brian Fuehrlein
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
How to Combat the Global Opioid Crisis.
Catherine Dennen A, Kenneth Blum, Eric Braverman R, et al.
PubMed (2023) Vol. 5, Iss. 4
Closed Access | Times Cited: 8
Catherine Dennen A, Kenneth Blum, Eric Braverman R, et al.
PubMed (2023) Vol. 5, Iss. 4
Closed Access | Times Cited: 8
The efficacy and safety of buprenorphine for the treatment of depression: A systematic review and meta-analysis
Natalie Riblet, Yinong Young‐Xu, Brian Shiner, et al.
Journal of Psychiatric Research (2023) Vol. 161, pp. 393-401
Open Access | Times Cited: 7
Natalie Riblet, Yinong Young‐Xu, Brian Shiner, et al.
Journal of Psychiatric Research (2023) Vol. 161, pp. 393-401
Open Access | Times Cited: 7
Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine
Ismene L. Petrakis, Sarah Meshberg‐Cohen, Charla Nich, et al.
American Journal on Addictions (2024) Vol. 33, Iss. 5, pp. 525-533
Closed Access | Times Cited: 2
Ismene L. Petrakis, Sarah Meshberg‐Cohen, Charla Nich, et al.
American Journal on Addictions (2024) Vol. 33, Iss. 5, pp. 525-533
Closed Access | Times Cited: 2
A comparison of mortality rates for buprenorphine versus methadone treatments for opioid use disorder
Daniel J. Gottlieb, Brian Shiner, Jessica E. Hoyt, et al.
Acta Psychiatrica Scandinavica (2022) Vol. 147, Iss. 1, pp. 6-15
Closed Access | Times Cited: 9
Daniel J. Gottlieb, Brian Shiner, Jessica E. Hoyt, et al.
Acta Psychiatrica Scandinavica (2022) Vol. 147, Iss. 1, pp. 6-15
Closed Access | Times Cited: 9
The cost of opioid use disorder-related conditions in Medicare
Tami L. Mark, William J. Parish, Ellen Weber, et al.
Drug and Alcohol Dependence (2023) Vol. 244, pp. 109778-109778
Closed Access | Times Cited: 4
Tami L. Mark, William J. Parish, Ellen Weber, et al.
Drug and Alcohol Dependence (2023) Vol. 244, pp. 109778-109778
Closed Access | Times Cited: 4
Suicidal behavior as a result of maladjustment of servicemen to the conditions of military service in Ukraine
Nataliia Mykhalchuk, Yurii Pelekh, Yevhen Kharchenko, et al.
European Journal of Clinical and Experimental Medicine (2023) Vol. 21, Iss. 1, pp. 90-107
Open Access | Times Cited: 4
Nataliia Mykhalchuk, Yurii Pelekh, Yevhen Kharchenko, et al.
European Journal of Clinical and Experimental Medicine (2023) Vol. 21, Iss. 1, pp. 90-107
Open Access | Times Cited: 4
A retrospective analysis of perioperative medications for opioid‐use disorder and tapering additional postsurgical opioids via a transitional pain service
Olivia Liu, David Leon, Ethan Gough, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 12, pp. 3010-3027
Closed Access | Times Cited: 1
Olivia Liu, David Leon, Ethan Gough, et al.
British Journal of Clinical Pharmacology (2024) Vol. 90, Iss. 12, pp. 3010-3027
Closed Access | Times Cited: 1
Medication Treatment for Opioid Use Disorder Reduces Suicide Risk
Larissa J. Mooney
American Journal of Psychiatry (2022) Vol. 179, Iss. 4, pp. 262-263
Closed Access | Times Cited: 6
Larissa J. Mooney
American Journal of Psychiatry (2022) Vol. 179, Iss. 4, pp. 262-263
Closed Access | Times Cited: 6
Suicide within 1 year of non-fatal overdose: Risk factors and risk reduction with medications for opioid use disorder
Molly Nowels, Paul R. Duberstein, Stephen Crystal, et al.
General Hospital Psychiatry (2023) Vol. 86, pp. 24-32
Closed Access | Times Cited: 2
Molly Nowels, Paul R. Duberstein, Stephen Crystal, et al.
General Hospital Psychiatry (2023) Vol. 86, pp. 24-32
Closed Access | Times Cited: 2
A Retrospective Analysis of Perioperative Medications for Opioid Use Disorder and Tapering Additional Postsurgical Opioids via a Transitional Pain Service Service
Olivia Liu, David Leon, Ethan Gough, et al.
Authorea (Authorea) (2024)
Open Access
Olivia Liu, David Leon, Ethan Gough, et al.
Authorea (Authorea) (2024)
Open Access
Overdose, personality correlates and treatment utilization in opioid use disorder
Matthew Jones
(2024)
Open Access
Matthew Jones
(2024)
Open Access
Genes and Genetic Testing in Addiction Medicine
Kenneth Blum, Margaret Madigan, Brian Fuehrlein, et al.
Elsevier eBooks (2024)
Closed Access
Kenneth Blum, Margaret Madigan, Brian Fuehrlein, et al.
Elsevier eBooks (2024)
Closed Access
Improving Linkage for Patients With Injection-Drug-Use-Related Endocarditis and Osteomyelitis to Medications for Opioid Use Disorder Through a Telephone Intervention
Cheyenne Harris, Payel Roy, Ann M. Mitchell, et al.
Journal of Addictions Nursing (2024) Vol. 35, Iss. 3, pp. 132-136
Closed Access
Cheyenne Harris, Payel Roy, Ann M. Mitchell, et al.
Journal of Addictions Nursing (2024) Vol. 35, Iss. 3, pp. 132-136
Closed Access
The annual trend of suicide rates from 2010 to 2021 in patients with cannabis use disorder – a national registry study
Martin Ø. Myhre, Eline Borger Rognli, Fredrik A. Walby, et al.
Social Psychiatry and Psychiatric Epidemiology (2024)
Open Access
Martin Ø. Myhre, Eline Borger Rognli, Fredrik A. Walby, et al.
Social Psychiatry and Psychiatric Epidemiology (2024)
Open Access
Outcomes Associated with Treatment with and Without Medications for Opioid Use Disorder
Ryan Mutter, Donna Spencer, Jeffrey McPheeters
The Journal of Behavioral Health Services & Research (2023) Vol. 50, Iss. 4, pp. 524-539
Closed Access | Times Cited: 1
Ryan Mutter, Donna Spencer, Jeffrey McPheeters
The Journal of Behavioral Health Services & Research (2023) Vol. 50, Iss. 4, pp. 524-539
Closed Access | Times Cited: 1
Association of opioid or other substance use disorders with health care use among patients with suicidal symptoms
Veer Vekaria, Braja Gopal Patra, Wenna Xi, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 156, pp. 209177-209177
Open Access | Times Cited: 1
Veer Vekaria, Braja Gopal Patra, Wenna Xi, et al.
Journal of Substance Use and Addiction Treatment (2023) Vol. 156, pp. 209177-209177
Open Access | Times Cited: 1
Development and validation of a prognostic index for mental health and substance use disorder burden
Talya Peltzman, Jenna Park, Brian Shiner
General Hospital Psychiatry (2023) Vol. 85, pp. 213-219
Closed Access | Times Cited: 1
Talya Peltzman, Jenna Park, Brian Shiner
General Hospital Psychiatry (2023) Vol. 85, pp. 213-219
Closed Access | Times Cited: 1
Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder
Madeline C. Frost, Julie Richards, John R. Blosnich, et al.
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109521-109521
Open Access | Times Cited: 1
Madeline C. Frost, Julie Richards, John R. Blosnich, et al.
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109521-109521
Open Access | Times Cited: 1